Background: Cardiovascular disease (CVD) affects the
heart and blood vessels. Older people are considerably more likely to suffer
from a heart attack or stroke or to develop coronary heart disease (commonly
called heart disease) and heart failure than younger people. Caring for older
patients with cardiac conditions is markedly different from caring for younger
patients with the same diagnosis.Objective: This study aimed to explore the characteristics and prevalence
of CVD and its associated comorbidities in older patients.Methods: This study reviewed the medical files of
all patients aged 65 years and older with CVD. Data such as sociodemographic
characteristics and CVD findings were collected from 1614 patients with CVD.
Design and Setting: Single-center retrospective cross-sectional study. Subjects: Almost two-thirds (1044, 64.7%) of the
patients were male, and one-third (570, 35.3%) were female; all had various
comorbidities. Results: Two main comorbidities associated with CVD were
hypertension (HTN) (1092, 67.7%) and diabetes mellitus (DM) (927, 57.4%). The
mean number of comorbidities associated with CVD was 2.61 (±1.1 SD), with a
higher average in males than in females (2.74 [±1.07] vs. 2.54 [±1.06]).Conclusion: Up to six associated comorbidities were
found in older patients with CVD, mostly with three comorbidities per patient.
Males accounted for two-thirds of the overall study population. HTN and
diabetes mellitus were the main CVD-associated comorbidities. Furthermore,
almost 95.2 patients were reduced every 5 years of age progression.
References
[1]
Roth, G.A., Mensah, G.A., Johnson, C.O., et al. (2020) Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update from the GBD 2019 Study. Journal of the American College of Cardiology, 76, 2982-3021. https://doi.org/10.1016/j.jacc.2020.11.010
[2]
World Health Organization (2017) Cardiovascular Disease. http://www.who.int/cardiovascular_diseases/en/
[3]
Kennedy, C. (2013) The Importance of Drug Discovery for Treatment of Cardiovascular Diseases. Future Medicinal Chemistry, 5, 355-357. https://doi.org/10.4155/fmc.13.20
[4]
Centers for Disease Control and Prevention (2019) Chronic Kidney Disease in the United States, 2019. US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta.
[5]
Gluckman, T.J., Wilson, M.A., Chiu, S.T., et al. (2020) Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction during the Coronavirus Disease 2019 Pandemic. JAMA Cardiology, 5, 1419-1424. https://doi.org/10.1001/jamacardio.2020.3629
[6]
Shrivastava, S.R., Shrivastava, P.S. and Ramasamy, J. (2018) HEARTS Package for the Management of Cardiovascular Diseases. Saudi Journal of Medicine & Medical Sciences, 6, 45-46. https://doi.org/10.4103/sjmms.sjmms_128_17
[7]
Alsuwaidan, A., Almedlej, N., Alsabti, S., et al. (2019) A Comprehensive Overview of Polypharmacy in Elderly Patients in Saudi Arabia. Geriatrics, 4, Article No. 36. https://doi.org/10.3390/geriatrics4020036
[8]
Cheitlin, M.D. (2003) Cardiovascular Physiology—Changes with Aging. The American Journal of Geriatric Cardiology, 12, 9-13. https://doi.org/10.1111/j.1076-7460.2003.01751.x
[9]
North, B.J. and Sinclair, D.A. (2012) The Intersection between Aging and Cardiovascular Disease. Circulation Research, 110, 1097-1108. https://doi.org/10.1161/CIRCRESAHA.111.246876
[10]
Pfeilschifter, J. and Beck, K.F. (2011) Oxidative Stress Injury in Glomerular Mesangium. In: Miyata, T., Eckardt, K.U. and Nangaku, M., Eds., Studies on Renal Disorders, Humana Press, Totowa, 3-23. https://doi.org/10.1007/978-1-60761-857-7_1
[11]
Jackson, C.F. and Wenger, N.K. (2011) Cardiovascular Disease in the Elderly Enfermedad Cardiovascular en el Anciano. Revista Española de Cardiología (English Edition), 64, 697-712. https://doi.org/10.1016/j.rec.2011.05.003
[12]
Coyle, D., Shahid, M., Dunford, E., et al. (2021) Estimating the Potential Impact of Australia’s Reformulation Programme on Households’ Sodium Purchases. BMJ Nutrition, Prevention & Health, 4, 49-58. https://doi.org/10.1136/bmjnph-2020-000173
[13]
Vermond, R.A., Geelhoed, B., Verweij, N., et al. (2015) Incidence of Atrial Fibrillation and Relationship with Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study from the Netherlands. Journal of the American College of Cardiology, 66, 1000-1007. https://doi.org/10.1016/j.jacc.2015.06.1314
[14]
Mureddu, G.F., Agabiti, N., Rizzello, V., et al. (2012) Prevalence of Preclinical and Clinical Heart Failure in the Elderly. A Population-Based Study in Central Italy. European Journal of Heart Failure, 14, 718-729. https://doi.org/10.1093/eurjhf/hfs052
[15]
Lee, J.H., Lim, N.K., Cho, M.C. and Park, H.Y. (2016) Epidemiology of Heart Failure in Korea: Present and Future. Korean Circulation Journal, 46, 658-664. https://doi.org/10.4070/kcj.2016.46.5.658
[16]
Ingle, G.K. and Nath, A. (2008) Geriatric Health in INDIA: Concerns and Solutions. Indian Journal of Community Medicine, 33, 214-218. https://doi.org/10.4103/0970-0218.43225
[17]
Ribera-Casado, J.M. (1999) Ageing and the Cardiovascular System. Zeitschrift für Gerontologie und Geriatrie, 32, 412-419. https://doi.org/10.1007/s003910050138
[18]
Alsuwaidan, S., Algharbi, A., Alyami, S., Almukhlifi, N. and Alsalamah, S. (2021) Prevalence of Comorbidity among Elderly. Global Journal of Aging & Geriatric Research, 1, Article ID: 000518.
[19]
Wu, C.Y., Hu, H.Y., Chou, Y.J., Huang, N., Chou, Y.C. and Li, C.P. (2015) High Blood Pressure and All-Cause and Cardiovascular Disease Mortalities in Community-Dwelling Older Adults. Medicine, 94, e2160. https://doi.org/10.1097/MD.0000000000002160
[20]
Rigaud, A.S. and Forette, B. (2001) Hypertension in Older Adults. The Journals of Gerontology: Series A, 56, M217-M225. https://doi.org/10.1093/gerona/56.4.M217
[21]
Panfoli, I., Puddu, A., Bertola, N., Ravera, S. and Maggi, D. (2021) The Hormetic Effect of Metformin: “Less Is More”? International Journal of Molecular Sciences, 22, Article No. 6297. https://doi.org/10.3390/ijms22126297
[22]
Halter, J.B., Musi, N., McFarland Horne, F.M., Crandall, J.P., Goldberg, A., Harkless, L., et al. (2014) Diabetes and Cardiovascular Disease in Older Adults: Current Status and Future Directions. Diabetes, 63, 2578-2589. https://doi.org/10.2337/db14-0020
[23]
Wang, B., Zhou, Y., Xiao, L., Guo, Y., Ma, J., Zhou, M., et al. (2018) Association of Lung Function with Cardiovascular Risk: A Cohort Study. Respiratory Research, 19, Article No. 214. https://doi.org/10.1186/s12931-018-0920-y
[24]
Shostak, E., Ameer, R., Gruden, J. and Jessurun, J. (2019) A Diagnostic Conundrum: Progressive Tubular Lung Mass in Asymptomatic Young Woman. CHEST, 155, e131-e135. https://doi.org/10.1016/j.chest.2019.02.318
[25]
Rosada, A., Kassner, U., Weidemann, F., König, M., Buchmann, N., Steinhagen-Thiessen, E., et al. (2020) Hyperlipidemias in Elderly Patients: Results from the Berlin Aging Study II (BASEII), a Cross-Sectional Study. Lipids in Health and Disease, 19, Article No. 92. https://doi.org/10.1186/s12944-020-01277-9
[26]
Félix-Redondo, F.J., Grau, M. and Fernández-Bergés, D. (2013) Cholesterol and Cardiovascular Disease in the Elderly. Facts and Gaps. Aging and Disease, 4, 154-169.
[27]
Carracedo, J., Alique, M., Vida, C., et al. (2020) Mechanisms of Cardiovascular Disorders in Patients with Chronic Kidney Disease: A Process Related to Accelerated Senescence. Frontiers in Cell and Developmental Biology, 8, Article 185. https://doi.org/10.3389/fcell.2020.00185
[28]
Xu, M., Chen, R., Liu, B., Chai, Y., Boer, D.D., Hu, P., et al. (2018) Psychosocial Determinants of Depression in the Community of the Elderly with Cardiovascular Disease. Psychiatry Research, 268, 123-130. https://doi.org/10.1016/j.psychres.2018.03.008
[29]
Abete, P., Della-Morte, D., Gargiulo, G., Basile, C., Langellotto, A., Galizia, G., et al. (2014) Cognitive Impairment and Cardiovascular Diseases in the Elderly. A Heart-Brain Continuum Hypothesis. Ageing Research Reviews, 18, 41-52. https://doi.org/10.1016/j.arr.2014.07.003
[30]
Stanton, B.R. (2011) The Neurology of Old Age. Clinical Medicine Journal, 11, 54-56. https://doi.org/10.7861/clinmedicine.11-1-54
[31]
van Bunderen, C.C., van Nieuwpoort, I.C., van Schoor, N.M., Deeg, D.J., Lips, P. and Drent, M.L. (2010) The Association of Serum Insulin-Like Growth Factor-I with Mortality, Cardiovascular Disease, and Cancer in the Elderly: A Population-Based Study. The Journal of Clinical Endocrinology & Metabolism, 95, 4616-4624. https://doi.org/10.1210/jc.2010-0940
[32]
Garcia, M., Mulvagh, S.L., Merz, C.N., Buring, J.E. and Manson, J.E. (2016) Cardiovascular Disease in Women: Clinical Perspectives. Circulation Research, 118, 1273-1293. https://doi.org/10.1161/CIRCRESAHA.116.307547
[33]
Maas, A.H. and Appelman, Y.E. (2010) Gender Differences in Coronary Heart Disease. Netherlands Heart Journal, 18, 598-602. https://doi.org/10.1007/s12471-010-0841-y
[34]
Robertson, R.M. (2001) Women and Cardiovascular Disease: The Risks of Misperception and the Need for Action. Circulation, 103, 2318-2320. https://doi.org/10.1161/01.CIR.103.19.2318
[35]
Kannel, W.B. and D’Agostino, R.B. (1995) The Importance of Cardiovascular Risk Factors in the Elderly. The American Journal of Geriatric Cardiology, 4, 10-23.
